Supreme Court Mulls Review Of Case On Antitrust Law In Drug Patent Settlements

Law360, New York (June 4, 2004, 12:00 AM EDT) -- In a closely watched controversy over patent settlements and antitrust law, drug makers Abbott Laboratories and Sandoz have urged the Supreme Court not to review a ruling that upholds the right of drug originators to pay generic firms to stay off the market.

The Supreme Court has scheduled a June 17 conference to determine if it should review the ruling.

Abbott and Geneva maintain that it would be premature for the Court to address this issue as several appeals courts are currently considering similar cases, according...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.